Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant humanised monoclonal antibody to human Nogo-A protein of the IgG1/kappa class

EU orphan designation number: EU/3/10/797   
Active ingredient: Recombinant humanised monoclonal antibody to human Nogo-A protein of the IgG1/kappa class
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Glaxo Group Ltd
980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Centralised Orphan - Designation EMA/OD/060/10 (2010)6942 of 01/10/2010
04/02/2014 Centralised Orphan - Change of address